Results 21 to 30 of about 75,890 (310)

Advanced pancreatic cancer: the standard of care and new opportunities

Oncology Reviews, 2018
Presentation of pancreatic cancer is localized, locally advanced or metastatic. With the later represented the main bulk (more than 80%). Despite the significant innovation in molecular analysis and therapeutic approach in many types of cancer in the ...
Amrallah A. Mohammad
doaj   +1 more source

Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer [PDF]

, 2006
In pancreatic cancer ( PC) accurate determination of treatment response by imaging often remains difficult. Various efforts have been undertaken to investigate new factors which may serve as more appropriate surrogate parameters of treatment efficacy ...
Anderson JS, Bekaii-Saab TS, Brambs HJ, Burris HA, Ebrahimi B, Glenn J, Gogas H, Goggins M, Heinemann V, Heinemann V, Heinemann V, Ishii H, Jamieson NB, Jiang XT, Katz A, Ko AH, Koprowski H, Louvet C, Lundin J, Maisey NR, Montgomery RC, Moore MJ, Ni XG, Okusaka T, Petra Stieber, Philip PA, Ralf Wilkowski, Saad ED, Safi F, Safi F, Sakar B, Sawaki A, Sperti C, Stathopoulos GP, Stefan Boeck, Stefan Holdenrieder, Steinberg W, Tanaka N, Tempero MA, Tian F, van Custem E, Vimalachandran D, Volker Heinemann, Wilkowski R, Wilkowski R, Wilkowski R, Willet CG, Wolff RA, Ziske C   +48 more
core   +1 more source

Diabetes and pancreatic cancer survival: A prospective cohort-based study [PDF]

, 2014
BACKGROUND: Diabetes is a risk factor for pancreatic cancer but its association with survival from pancreatic cancer is poorly understood. Our objective was to investigate the association of diabetes with survival among pancreatic cancer patients in a ...
A Hwang, A T Toriola, AB Miller, BM Oaks, C Cowie, CK Chu, CS Zhu, D Linehan, E Rozengurt, EE Calle, G Colditz, I Regel, L Dalidowitz, M Dandona, N Sadeghi, R Siegel, R Stolzenberg-Solomon, RP Sah, RR McWilliams, SH Olson, SR Seshasai   +20 more
core   +3 more sources

Current Oncological Treatment of Patients with Pancreatic Cancer in Germany: Results from a National Survey on behalf of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the Germany Cancer Society [PDF]

, 2009
Background: No data have previously been available regarding the current treatment of patients with pancreatic cancer (PC) in German hospitals and medical practices.
Boeck, Stefan, Bruns, Christiane J., Heinemann, Volker, Jauch, Karl-Walter, Sargent, Mirja, Schäfer, Claus, Seufferlein, Thomas   +6 more
core   +1 more source

Neoadjuvant treatment in pancreatic cance. Evidence-based medicine? A systematic review and meta-analysis [PDF]

, 2017
Neoadjuvant treatment in non-metastatic pancreatic cancer (PaC) has the theoretical advantages of downstaging the tumor, sterilizing any present systemic undetectable disease, selecting patients for surgery and administering therapy to each patient.
Antolino, Laura, Aurello, Paolo, D'Angelo, Francesco, DE SIENA, Martina, Farcomeni, Alessio, KAZEMI NAVA, Andrea, Nigri, Giuseppe, Petrucciani, Niccolo', Ramacciato, Giovanni, Sirimarco, Dario, Valabrega, Stefano   +10 more
core   +1 more source

Locally Advanced Pancreatic Cancer

, 2022
With a worldwide incidence of approximately 496,000 new cases and 466,000 deaths in 2020, pancreatic cancer is among the most deadliest of cancers. The majority of patients present with an advanced stage of cancer at diagnosis. This includes 30-40% of patients with locally advanced pancreatic cancer (LAPC), due to extensive perivascular tumor ...
openaire   +2 more sources

Ablation Strategies for Locally Advanced Pancreatic Cancer [PDF]

Digestive Surgery, 2016
With the advent of novel and somewhat effective chemotherapy against pancreas cancer, several groups developed a new interest on locally advanced pancreatic cancer (LAPC). Unresectable tumors constitute up to 80% of pancreatic cancer (PC) at the time of diagnosis and are associated with a 5-year overall survival of less than 5%. To control those tumors
Linecker, Michael, Pfammatter, Thomas, Kambakamba, Patryk, DeOliveira, Michelle L   +3 more
openaire   +2 more sources

Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer [PDF]

, 2007
Objective: To date, no standard regimen for salvage chemotherapy after gemcitabine (Gem) failure has been defined for patients with advanced pancreatic cancer (PC). Oral capecitabine (Cap) has shown promising activity in first-line chemotherapy trials in
Boeck, Stefan, Bruns, Christiane J., Golf, Alexander, Haas, Michael, Heinemann, Volker, Issels, Rolf-Dieter, Laessig, Dorit, Moosmann, Nicolas, Schulz, Christoph, Wilkowski, Ralf   +9 more
core   +1 more source

Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients with Advanced Pancreatic Cancer: A Retrospective Analysis. [PDF]

, 2018
BackgroundContinuous-infusion 5-fluorouracil (5FU) and calcium leucovorin plus nab-paclitaxel and oxaliplatin have been shown to be active in patients with pancreatic cancer.
Bedford, Rudolph, Donahue, Timothy, Hines, O Joe, Hoos, William, Isacoff, William H, Rahib, Lola, Reber, Howard A, Upfill-Brown, Alexander   +7 more
core   +1 more source

Arterial reconstruction by anastomosis of left gastric artery and superior mesenteric artery for locally advanced pancreatic carcinoma

Journal of Vascular Surgery Cases and Innovative Techniques, 2019
We report the case of a 61-year-old man with pancreatectomy with arterial resection and reconstruction and extended lymph node dissection because of locally advanced pancreatic cancer.
Ling Liu, PhD, Changku Jia, MD, Sunbing Xu, PhD, Minwei Shen, MD   +3 more
doaj   +1 more source